BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Timirci-Kahraman O, Ozkan NE, Turan S, Farooqi AA, Verim L, Ozturk T, Inal-Gultekin G, Isbir T, Ozturk O, Yaylim I. Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand and death receptor genes contribute to susceptibility to bladder cancer. Genet Test Mol Biomarkers 2015;19:309-15. [PMID: 25955868 DOI: 10.1089/gtmb.2015.0050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Güldal Inal Gültekin, Özlem Timirci Kahraman, Murat Işbilen, Saliha Durmuş, Tunahan Çakir, İlhan Yaylim, Turgay Isbir. Six potential biomarkers for bladder cancer: key proteins in cell-cycle division and apoptosis pathways. J Egypt Natl Canc Inst 2022;34:54. [PMID: 36529823 DOI: 10.1186/s43046-022-00153-0] [Reference Citation Analysis]
2 Cheng R, Liu X, Wang Z, Tang K. ABT‑737, a Bcl‑2 family inhibitor, has a synergistic effect with apoptosis by inducing urothelial carcinoma cell necroptosis. Mol Med Rep 2021;23:412. [PMID: 33786632 DOI: 10.3892/mmr.2021.12051] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
3 Sandoughi M, Salimi S, Shahraki-Ghadimi H, Saravani M. The Impact of TRAIL (C1595T and G1525A) and DR4 (rs20576) Gene Polymorphisms on Systemic Lupus Erythematosus. Biochem Genet 2020;58:649-59. [PMID: 32342239 DOI: 10.1007/s10528-020-09966-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
4 Lipunova N, Wesselius A, Cheng KK, van Schooten FJ, Cazier JB, Bryan RT, Zeegers MP. Systematic Review: Genetic Associations for Prognostic Factors of Urinary Bladder Cancer. Biomark Cancer 2019;11:1179299X19897255. [PMID: 31908559 DOI: 10.1177/1179299X19897255] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
5 Koç Erbaşoğlu Ö, Horozoğlu C, Ercan Ş, Kara HV, Turna A, Farooqi AA, Yaylım İ. Effect of trail C1595T variant and gene expression on the pathogenesis of non-small cell lung cancer. Libyan J Med 2019;14:1535746. [PMID: 30481147 DOI: 10.1080/19932820.2018.1535746] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
6 Mari A, D'Andrea D, Abufaraj M, Foerster B, Kimura S, Shariat SF. Genetic determinants for chemo- and radiotherapy resistance in bladder cancer. Transl Androl Urol 2017;6:1081-9. [PMID: 29354495 DOI: 10.21037/tau.2017.08.19] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 4.2] [Reference Citation Analysis]